Identification of HM13 as a prognostic indicator and a predictive biomarker for immunotherapy in hepatocellular carcinoma

BACKGROUND: Histocompatibility minor 13 (HM13) is a signal sequence stubbed intramembrane cleavage catalytic protein that is essential for cell signaling, intracellular communication, and cancer. However, the expression of HM13 and its prognostic value, association with tumor-infiltrating immune cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Genhao, Lv, Xianping, Yang, Qiankun, Liu, Hongchun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375928/
https://www.ncbi.nlm.nih.gov/pubmed/35964022
http://dx.doi.org/10.1186/s12885-022-09987-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375928/
https://www.ncbi.nlm.nih.gov/pubmed/35964022
http://dx.doi.org/10.1186/s12885-022-09987-2

Ejemplares similares